Clear Secure's stock jumped 23% on Feb. 25, 2026, after exceeding earnings expectations and announcing strong 2026 guidance.

Claire’s UK & Ireland entered administration in January 2026, closing 154 stores and threatening 1,355 jobs.

Polaroid Therapeutics gained EU approval for POLTX_Fiber™, a non-antibiotic wound dressing that prevents infection and promotes healing.

Chancery Royalty secured a $20M royalty deal with KEFI for Ethiopia’s Tulu Kapi gold project, enabling full funding and commissioning by early 2028.

Bureau Veritas grew revenue 6.5% in 2025, met targets, and raised dividends and buybacks.

The EU, U.S., and Canada approved Galderma’s updated Restylane syringes with better design, labeling, and eco-friendly packaging.

China’s dominance in commercial shipping threatens U.S. security, prompting calls for American industry revival.

Shaftesbury Capital posted a 35% profit surge in 2025, boosted by strong leasing and rising rents, and raised its dividend by 14%.

India’s road construction slows in 2026-27 due to fewer projects and monsoon delays, despite rising toll collections.

Coupang’s interim CEO testified for seven hours about a data breach and South Korea’s regulatory actions, under scrutiny for possible bias against U.S. firms.